Blog >
pharmaceutical

pharmaceutical

Umbrex is pleased to welcome Holger Bernd Mueller with Tmmune AG.  Holger built his career on the two pillars of strategy consulting and commercialization of innovations in the pharmaceutical industry. After his forming education at Bain & Company, Holger joined Novartis Pharma in headquarter- and country-organization roles, covering the entire lifecycle of a pharmaceutical drug […]

In this article, Sohil Parekh turns his focus to healthcare and the challenges faced by people with rare diseases and their families.  We stood under bright blue skies in Boston’s Fort Point neighborhood. The late Spring sun shone down on us. The morning seemed colder than it was as a light breeze blew in from […]

Umbrex is pleased to welcome Sven Sauer with SVEN SAUER HEALTHCARE CONSULTING. Sven has over 25 years of experience in pharma and healthcare with deep knowledge and understanding of the German and various other European healthcare systems. In 2011, he founded SVEN SAUER HEALTHCARE CONSULTING, which successfully provides services to the pharmaceutical and medical devices […]

Umbrex is pleased to welcome Seth Townsend with Tonisgah Group. Seth  spent 5 years at McKinsey as part of the Healthcare practice, leading efforts across sales growth, pricing, operations, due diligence, M&A, and corporate strategy for companies in the pharmaceuticals, medical devices, and healthcare industry.  Following his time at McKinsey, Seth worked at Novartis where […]

dan-markovitz-asics-tiger-san-francisco-ca

  Dan Markovitz identifies the difference between facts and data and why you need both to make a fully informed assessment.  Taiichi Ohno said, “Data is of course important in manufacturing, but I place the greatest emphasis on facts.” You can leave out the word “manufacturing,” and apply the concept to anything in your company […]